Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Sanofi”

Praluent® (Alirocumab) Pregnancy Exposure Registry: An OTIS Pregnancy Surveillance StudyTerminated
NCT03379558N/AUpdated Nov 23, 2020
Sponsor: Regeneron Pharmaceuticals
Hypercholesterolemia
United States
Tofogliflozin GLP-1 Analogue Combination TrialCompleted
NCT02537834Phase 4Updated Nov 17, 2020
Sponsor: Kowa Company, Ltd.
Type 2 Diabetes Mellitus
Japan
Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IGlarLixiCompleted
NCT03130426Phase 3Updated Nov 13, 2020
Sponsor: Population Health Research Institute
Type 2 Diabetes Mellitus
Canada
Observational Study of Long-Term Joint Health Outcome in Hemophilia PatientUnknown
NCT04618237N/AUpdated Nov 5, 2020
Sponsor: Taipei Medical University Hospital
Hemophilia · Arthropathy
Taiwan
Phase 2a Extension Study of Ataluren (PTC124) in Duchenne Muscular Dystrophy (DMD)Terminated
NCT00759876Phase 2Updated Oct 29, 2020
Sponsor: PTC Therapeutics
Duchenne Muscular Dystrophy
United States
A Study of the Safety and Pharmacokinetics of SAR245409 Tablets in Patients With Solid Tumors or LymphomaCompleted
NCT01596270Phase 1Updated Oct 28, 2020
Sponsor: Sanofi
Neoplasm Malignant
United States
The Korean TITRATION Study: Comparison of the Self-titration Methods for Glargine-300Completed
NCT03406663NAUpdated Oct 22, 2020
Sponsor: Seoul National University Hospital
Type 2 Diabetes Mellitus
South Korea
Impact of the Arrival on the French Market of New First Line Oral Treatments on the Delay Between MS Onset and First Disease Modifying Treatment (DMTs) AdministrationCompleted
NCT03308994N/AUpdated Oct 22, 2020
Sponsor: University Hospital, Caen
C10.114.375.500
France
Phase I Trial of PACE for Metastatic Prostate CancerWithdrawn
NCT03110588Phase 1Updated Oct 19, 2020
Sponsor: University of Alabama at Birmingham
Metastatic Prostate Cancer
United States
TroVax Renal Immunotherapy Survival TrialCompleted
NCT00397345Phase 3Updated Oct 19, 2020
Sponsor: Oxford BioMedica
Clear Cell Renal Carcinoma
United States, France, Germany, Israel, Poland +5 more
Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and ThymoglobulinCompleted
NCT00822770Phase 1, Phase 2Updated Oct 14, 2020
Sponsor: M.D. Anderson Cancer Center
Stem Cell Transplantation · Leukemia
United States
Pompe Disease QMUS and EIMCompleted
NCT02742298NAUpdated Sep 25, 2020
Sponsor: Duke University
Pompe Disease
United States
Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)Terminated
NCT00506948Phase 2Updated Sep 24, 2020
Sponsor: M.D. Anderson Cancer Center
Hematological Malignancies · Myelodysplastic Syndrome · Leukemia · Lymphoma
United States
COMPOUND (INN): HOE490O - GLIMEPIRIDE / METFORMIN HCl (Amaryl® M)0 (Glimepiride/Metformin Hydrochloride Immediate Release Combination Tablet) in Fed Conditions in Healthy Male and/or Female Subjects.Withdrawn
NCT02395237Phase 1Updated Sep 18, 2020
Sponsor: Pharmaceutical Research Unit, Jordan
Healthy
Jordan
Exploratory Study Of The ERCC-1 GeneCompleted
NCT00846482NAUpdated Sep 16, 2020
Sponsor: Albert Einstein College of Medicine
Colon Cancer · Rectal Cancer
United States
Adacel® Booster Vaccination for CMI Assay DevelopmentCompleted
NCT04543669Phase 4Updated Sep 10, 2020
Sponsor: Dalhousie University
Pertussis
Canada
Intraoperative Versus Postoperative Thymoglobulin in Lung TransplantationWithdrawn
NCT00592306Phase 3Updated Sep 10, 2020
Sponsor: University of California, Los Angeles
Lung Transplant
United States
Pertussis Maternal Immunization StudyCompleted
NCT00553228Phase 2, Phase 3Updated Aug 27, 2020
Sponsor: Scott Halperin
Pregnant Women
Canada
A Study to Assess the Efficacy and Safety of Dupilumab in Participants With Severe Atopic Dermatitis (AD) That Are Not Controlled With Oral Cyclosporine A (CSA) or for Those Who Cannot Take Oral CSA Because it is Not Medically AdvisableCompleted
NCT02755649Phase 3Updated Aug 20, 2020
Sponsor: Regeneron Pharmaceuticals
Atopic Dermatitis
Austria, Belgium, Germany, Ireland, Netherlands +5 more
Diabetes To Go: An Inpatient Diabetes Survival Skills Education ProgramCompleted
NCT03023228NAUpdated Aug 18, 2020
Sponsor: Medstar Health Research Institute
Diabetes Mellitus · Hyperglycemia
Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD)Completed
NCT03345914Phase 3Updated Aug 13, 2020
Sponsor: Regeneron Pharmaceuticals
Dermatitis, Atopic
United States, Canada, Czechia, Germany, Poland +1 more
Alemtuzumab and Clofarabine for Relapsed or Refractory Acute Lymphoblastic LeukemiaTerminated
NCT00983528Phase 1, Phase 2Updated Aug 12, 2020
Sponsor: University of California, San Diego
Acute Lymphoblastic Leukemia
United States
Open-Label Extension of Study R727-CL-1003 (NCT01266876) to Evaluate the Long-Term Safety and Efficacy of Alirocumab (REGN727) in Participants With Heterozygous Familial Hypercholesterolemia (HeFH)Completed
NCT01576484Phase 2Updated Aug 5, 2020
Sponsor: Regeneron Pharmaceuticals
Hypercholesterolemia · Heterozygous Familial Hypercholesterolemia
United States, Canada
Study of Ataluren (PTC124) in Nonambulatory Participants With Nonsense-Mutation-Mediated Duchenne/Becker Muscular Dystrophy (nmDMD/BMD)Terminated
NCT01009294Phase 2Updated Jul 29, 2020
Sponsor: PTC Therapeutics
Duchenne Muscular Dystrophy · Becker Muscular Dystrophy
United States, United Kingdom
Sargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II MelanomaWithdrawn
NCT01826864Phase 3Updated Jul 27, 2020
Sponsor: Jonsson Comprehensive Cancer Center
Stage IB Melanoma · Stage IIA Melanoma · Stage IIB Melanoma · Stage IIC Melanoma
United States

Previous page Next page